Your shopping cart is currently empty

PB1 is a highly-effective intracellular disulfide reducing agent with notable attributes such as excellent cell permeability, the capacity to generate a substantial intracellular concentration gradient, and remarkable stability. It serves as a borane-protected TCEP (tris(2-carboxyethyl)phosphine) analogue. PB1 demonstrates the potential to enhance the survival of retinal ganglion cells following axotomy in vitro at concentrations in the nanomolar and picomolar range. Consequently, PB1 has proven instrumental in the study of neuroprotective properties[1][2][3].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $376 | 6-8 weeks | 6-8 weeks | |
| 25 mg | $1,140 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,490 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,360 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $345 | 6-8 weeks | 6-8 weeks |
| Description | PB1 is a highly-effective intracellular disulfide reducing agent with notable attributes such as excellent cell permeability, the capacity to generate a substantial intracellular concentration gradient, and remarkable stability. It serves as a borane-protected TCEP (tris(2-carboxyethyl)phosphine) analogue. PB1 demonstrates the potential to enhance the survival of retinal ganglion cells following axotomy in vitro at concentrations in the nanomolar and picomolar range. Consequently, PB1 has proven instrumental in the study of neuroprotective properties[1][2][3]. |
| In vitro | PB1 significantly enhances the activation of the BDNF effector ERK1/2 and supports RGC survival [1]. |
| In vivo | PB1 (150 μM; intraocular injection; 1 week) attenuates the loss of both retinal ganglion cells (RGC) soma and axons in experimental glaucoma[1]. PB1 single dose limits the biological activity in vivo. PB1 (0.001~100 μM; 72 hours) effectively rescues acutely axotomized retinal ganglion cells[1][2]. |
| Molecular Weight | 296.11 |
| Formula | C14H22BO4P |
| Cas No. | 188714-28-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (337.71 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (11.14 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.